Biotech & Health Extension
Program
sponsored by 100 Plus Capital

UPCOMING PROGRAM
SEMINAR SUMMARIES
Recordings, written summaries and slides of previous keynotes

Maila Reeves
Dr. Stephanie Manson-Brown
Claudia Von Boeselager
Nikolina Lauc
Women’s Health and Longevity
View keynote summary >

Dylan Livingston, Alliance for Longevity Initiatives
Longevity Policy Opportunities
View keynote summary >

Dylan Livingston, Alliance for Longevity Initiatives
Joe DeSantis
Policy Focus
View keynote summary >

Dylan Livingston, Alliance for Longevity Initiatives | Longevity Policy Focus
View keynote summary >

Sergey Young, Longevity Vision Fund
Neil Littman, Bioverge
Longevity Investing
View keynote summary >

Kristen Fortney, Bioage
Building a pipeline of clinical-stage therapies to target aging
View keynote summary >

David Furman, Buck Institute
Systems Immunology of Aging to Enable Precision Preventative Medicine
View keynote summary >

Alexander Fedintsev, lifespan.io
Biohacking – A necessary component of a strategy for radical life extension
View keynote summary >

Daniel Belsky, Columbia University
Terrie Moffitt, Duke University.
The DunedinPoAm DNA Methylation Algorithm
View keynote summary >

Michael Snyder, Stanford University
Monitoring Personal Health and Ageotypes Using Big Data
View keynote summary >

Michael Levin, Tufts Center for Regenerative and Developmental Biology
Bioelectric Networks: Taming the Collective Intelligence of Cells for Regenerative Medicine
View keynote summary >

Daniel Ives, Shift Bioscience
Drug Target Discovery for Cellular Rejuvenation by ‘Driver’ Clocks
View keynote summary >

Nir Barzilai, Albert Einstein School of Medicine
TAME Q&A: Lessons for Progress on Aging
View keynote summary >

Keith Murphy, Organovo, Viscient Biosciences
David Gobel, Methuselah Foundationt
Patient Trials in a Dish” Paths Forward
View keynote summary >

Vadim Gladyshev, Harvard
Gordan Lauc, GlycanAge
Biomarker & Aging Clock Development
View keynote summary >

Alex Zhavoronkov, Deep Longevity & Insilico Medicine
Longevity as a Service: AI & Aging Clocks
View keynote summary >

Dylan Livingston, ALARMA
ALARMA (America’s Longevity, Aging and Regenerative Medicine Association)
View keynote summary >

Christopher Leptak, CDER Biomarker Qualification Program, FDA
Biomarkers and Drug Development: Regulatory Perspective
View keynote summary >

Ronald Kohanski, National Institute on Aging
Institutional perspective: What work could dramatically advance progress on aging from an NIA perspective?
View keynote summary >

Jean Hebert, Albert Einstein School of Medicine
Brain Cell Replacement as the Cornerstone to Beating Aging
View keynote summary >

![]() |
![]() |
![]() |
Brian Kennedy, Buck Institute
Joris Deelen, Max Planck Institute for Aeging
Lynne Cox, Oxford University
Underincentivized Basic Research In Health Extension
View keynote summary >
Brian Kennedy, Buck Institute
Joris Deelen, Max Planck Institute for Aeging
Lynne Cox, Oxford University
Underincentivized Basic Research In Health Extension
View keynote summary >

![]() |
![]() |
![]() |
Sonia Arrison, 100 Plus Capital
Karl Pfleger, Agingbiotech.info
Mike West, AgeX
Industry Blindspots for Dramatically Advancing Progress in Health Extension
View keynote summary >
Sonia Arrison, 100 Plus Capital
Karl Pfleger, Agingbiotech.info
Mike West, AgeX
Industry Blindspots for Dramatically Advancing Progress in Health Extension
View keynote summary >

![]() |
![]() |
Allison Duettmann, Foresight Institute
Sonia Arrison, 100 Plus Capital
Define 2021 Goals
View keynote summary >
Allison Duettmann, Foresight Institute
Sonia Arrison, 100 Plus Capital
Define 2021 Goals
View keynote summary >